Literature DB >> 17960579

Estimating drug efficacy and viral dynamic parameters: HIV and HCV.

Alan S Perelson1, Ruy M Ribeiro.   

Abstract

Mathematical models have proven valuable in understanding the in vivo dynamics of human immunodeficiency virus type 1 (HIV-1), the virus that causes AIDS, and hepatitis C virus (HCV), the virus that causes hepatitis C infection. By comparing mathematical models with the data obtained from patients being treated with antiviral drugs, it has been possible to determine many quantitative features of these infections. The most dramatic finding has been that even though AIDS and hepatitis C are diseases that occur on a timescale of one or more decades, there are very rapid dynamical processes that occur on timescales of hours to days, as well as slower processes that occur on timescales of weeks to months. We show how dynamical modeling and parameter estimation techniques have uncovered these important features of HIV and HCV infection and subsequently impacted the way in which patients are treated with potent antiviral drugs. Published in 2007 by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 17960579     DOI: 10.1002/sim.3116

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part II: application to drug development.

Authors:  Jing Fang; Pravin R Jadhav
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-07-08       Impact factor: 2.745

2.  Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients.

Authors:  Itaru Ozeki; Jun Akaike; Yoshiyasu Karino; Tomohiro Arakawa; Yasuaki Kuwata; Takumi Ohmura; Takahiro Sato; Naohiro Kamiya; Ichimaro Yamada; Kazuaki Chayama; Hiromitsu Kumada; Joji Toyota
Journal:  J Gastroenterol       Date:  2011-05-10       Impact factor: 7.527

3.  Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model.

Authors:  Thi Huyen Tram Nguyen; Emmanuelle Comets; France Mentré
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-11       Impact factor: 2.745

Review 4.  Mathematical modeling of within-host Zika virus dynamics.

Authors:  Katharine Best; Alan S Perelson
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

5.  HIV-1 drug discovery: targeting folded RNA structures with branched peptides.

Authors:  Jessica E Wynn; Webster L Santos
Journal:  Org Biomol Chem       Date:  2015-06-07       Impact factor: 3.876

6.  Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks.

Authors:  Bradley G Wagner; J Gerardo Garcia-Lerma; Sally Blower
Journal:  Sci Rep       Date:  2012-03-19       Impact factor: 4.379

7.  Connecting within-host dynamics to the rate of viral molecular evolution.

Authors:  Kayla M Peck; Carmen H S Chan; Mark M Tanaka
Journal:  Virus Evol       Date:  2015-10-02

8.  A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein.

Authors:  Anurag Sethi; Jianhui Tian; Cynthia A Derdeyn; Bette Korber; S Gnanakaran
Journal:  PLoS Comput Biol       Date:  2013-05-16       Impact factor: 4.475

9.  Extracts of medicinal herb Sanguisorba officinalis inhibit the entry of human immunodeficiency virus type one.

Authors:  Jianguo Liang; Jianping Chen; Zhiwu Tan; Jie Peng; Xiao Zheng; Kenji Nishiura; Jenny Ng; Zhiyu Wang; Dongmei Wang; Zhiwei Chen; Li Liu
Journal:  Yao Wu Shi Pin Fen Xi       Date:  2013-12

10.  Strong epistatic selection on the RNA secondary structure of HIV.

Authors:  Raquel Assis
Journal:  PLoS Pathog       Date:  2014-09-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.